KEY POINTS:
New Zealand's medicines watchdog has asked doctors to watch for psychiatric disorders in patients taking cholesterol-lowering drugs.
"The reactions of particular concern are those of aggressive behaviour, but also memory impairment, as well as mood, cognitive, sleep and perception disorders," Medsafe said in an advisory to GPs, the Sunday Star-Times reported yesterday.
Dr Stewart Jessamine, Medsafe's senior medical adviser, said the side-effects of the drugs were rare.
